Skip to main content

Want a detailed portfolio tracker?

Cingulate (CING) P/E (2021 - 2026)

Cingulate (CING) P/E from Dec 31, 2021 to Jun 3, 2026. The TTM Cingulate (CING) P/E is -1.25. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Cingulate (CING)

YearP/EChange
2026-1.25+18.92%
2025-1.05+208.74%
2024-0.34-92.61%
2023-4.62-67.86%
2022-14.38-93.89%
2021-235.48N/A

Comparison Cingulate (CING) P/E with competitors

Cingulate (CING) P/E is -1.25.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.14%
NBYStablecoin Development Corp0.10-108.15%
ENLVEnlivex Therapeutics Ltd0.15-111.98%
FGENFibroGen Inc0.24-119.15%
TRAWTraws Pharma Inc0.47-137.72%
FBIOFortress Biotech Inc0.71-156.32%
CHRSCoherus Biosciences Inc0.98-178.03%
ORMPOramed Pharmaceuticals Inc1.47-217.54%
AGENAgenus Inc2.05-263.42%
VIVSVivoSim Labs Inc2.54-302.29%
INVAInnoviva Inc3.19-354.36%
CRMDCorMedix Inc3.65-390.84%
ABEOAbeona Therapeutics Inc4.20-435.45%
VXRTVaxart Inc4.26-439.97%
CVACCureVac N.V.4.45-454.65%
SRPTSarepta Therapeutics Inc4.62-468.90%
GLPGGalapagos NV4.86-487.61%
RIGLRigel Pharmaceuticals4.92-492.46%
ZVRAZevra Therapeutics Inc4.97-496.80%
ABUSArbutus Biopharma Corp5.69-554.22%
CGENCompugen Ltd7.38-689.06%
AUPHAurinia Pharmaceuticals Inc9.25-838.04%
ACADAcadia Pharmaceuticals Inc9.59-864.89%
OMEROmeros Corporation9.88-888.46%
PLXProtalix BioTherapeutics Inc9.91-890.51%
SPROSpero Therapeutics Inc10.73-956.37%
ADMAAdma Biologics Inc11.33-1003.91%
SVASinovac Biotech Ltd11.44-1012.32%
TBPHTheravance Biopharma Inc11.78-1039.49%
HRMYHarmony Biosciences Holdings Inc12.18-1071.71%
TGTXTG Therapeutics Inc13.18-1151.41%
INCYIncyte Corp13.38-1167.57%
SABSSAB Biotherapeutics Inc14.06-1221.47%
XOMAXOMA Corp14.95-1292.28%
REGNRegeneron Pharmaceuticals Inc14.98-1295.07%
PBYIPuma Biotechnology Inc15.05-1300.67%
EXELExelixis Inc15.79-1360.05%
NAGENiagen Bioscience Inc16.35-1404.74%
CPRXCatalyst Pharmaceuticals Inc17.34-1483.70%
MDXGMimedx Group Inc17.38-1486.14%
ARGXArgen X SE23.07-1940.57%
HALOHalozyme Therapeutics Inc23.20-1950.86%
XOMAOXOMA Corp25.34-2121.92%
VRTXVertex Pharmaceuticals Inc25.66-2146.73%
XOMAPXOMA Corp25.67-2147.87%
CTMXCytomX Therapeutics Inc25.70-2150.09%
ASNDAscendis Pharma A/S26.35-2202.44%
RPRXRoyalty Pharma plc - Class A27.50-2293.49%
SLNOSoleno Therapeutics Inc29.02-2414.74%
LGNDLigand Pharmaceuticals Inc - Class B30.19-2508.17%
BMRNBiomarin Pharmaceutical Inc37.51-3092.20%
APLSApellis Pharmaceuticals Inc39.02-3212.97%
KRYSKrystal Biotech Inc39.70-3266.93%
GMABGenmab40.20-3307.30%
ONCBeiGene Ltd67.03-5447.17%
TECHBio-Techne Corp68.59-5572.27%
VCELVericel Corp80.63-6532.32%
PHARPharming Group N.V.87.74-7099.60%
ALNYAlnylam Pharmaceuticals Inc124.93-10066.77%
TLXTelix Pharmaceuticals Ltd139.89-11259.99%
CORTCorcept Therapeutics Inc158.39-12735.75%